Focus: Hyperfine is a medical device company specializing in portable MRI scanners, targeting neurology and oncology applications with innovative imaging technology designed for point-of-care accessibility.
Profile data last refreshed 10h ago · AI intelligence enriched 1w ago
Stable — net -1 jobs in 30d
3 added, 4 removed. Backfill posture.
Hyperfine is a hardware-focused biotech with solid commercialization traction but limited visibility into financial health and growth runway—suitable for engineers and commercial professionals who tolerate early-stage risk for hardware innovation upside.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Hyperfine
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Hyperfine's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness - Business Wire
Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness Business Wire
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026 - Business Wire
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026 Business Wire
Hyperfine, Inc. Reaffirms Earnings Guidance for the Year 2026 - www.marketscreener.com
Hyperfine, Inc. Reaffirms Earnings Guidance for the Year 2026 www.marketscreener.com
Hyperfine stock gained 2.54 percent after Gulf distributor deal - AD HOC NEWS
Hyperfine stock gained 2.54 percent after Gulf distributor deal AD HOC NEWS
Hyperfine appoints Roots as distribution partner for Kuwait, UAE - TipRanks
Hyperfine appoints Roots as distribution partner for Kuwait, UAE TipRanks
Prenuvo launches whole-body MRI research network - AuntMinnie
Prenuvo launches whole-body MRI research network AuntMinnie
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Feasibility, image quality, and analytic usability of mobile 64 mT ultra-low-field MRI for infant brain imaging at 3 and 12 months in southern Malawi.
Portable Ultra-Low-Field MRI in Outpatient Neurology: An Examination of Clinical Performance and Patient Experience.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo